Your browser doesn't support javascript.
loading
Losartan to reduce inflammation and fibrosis endpoints in HIV disease.
Baker, Jason V; Wolfson, Julian; Collins, Gary; Morse, Caryn; Rhame, Frank; Liappis, Angelike P; Rizza, Stacey; Temesgen, Zelalem; Mystakelis, Harry; Deeks, Steven; Neaton, James; Schacker, Timothy; Sereti, Irini; Tracy, Russell P.
  • Baker JV; Hennepin Healthcare Research Institute.
  • Wolfson J; University of Minnesota, Minneapolis, Minnesota.
  • Collins G; University of Minnesota, Minneapolis, Minnesota.
  • Morse C; University of Minnesota, Minneapolis, Minnesota.
  • Rhame F; Wake Forest Baptist Medical Center, Winston Salem, North Carolina.
  • Liappis AP; Allina Health, Minneapolis, Minnesota.
  • Rizza S; Washington VA Medical Center, Washington, District of Columbia.
  • Temesgen Z; Mayo Clinic, Rochester, Minnesota.
  • Mystakelis H; Mayo Clinic, Rochester, Minnesota.
  • Deeks S; NIAID/ NIH, Bethesda, Maryland.
  • Neaton J; University of California San Francisco, San Francisco, California.
  • Schacker T; University of Minnesota, Minneapolis, Minnesota.
  • Sereti I; University of Minnesota, Minneapolis, Minnesota.
  • Tracy RP; NIAID/ NIH, Bethesda, Maryland.
AIDS ; 35(4): 575-583, 2021 03 15.
Article en En | MEDLINE | ID: mdl-33252490
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Losartán Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Losartán Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article